Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128966) titled 'Direct to Patient Minimal Risk Biospecimen and Data Collection Research' on Aug. 11.

Study Type: Observational [Patient Registry]

Primary Sponsor: Joined Bio

Condition: Healthy Lupus Celiac Kidney Disease Chronic Dermatologic

Intervention: Other: Observation

Recruitment Status: Not recruiting

Date of First Enrollment: September 1, 2025

Target Sample Size: 100000

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07128966

Disclaimer: Curated by HT Syndication....